ArticleJCO precision oncology2022

APOBEC Mutational Signatures in Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancers Are Associated With Poor Outcomes on CDK4/6 Inhibitors and Endocrine Therapy.

Sarah Sammons et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.